1. Home
  2. COEP vs NRT Comparison

COEP vs NRT Comparison

Compare COEP & NRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
    SELLHOLDBUYas of 8 hours ago
  • NRT
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • COEP 2017
  • NRT 1975
  • Country
  • COEP United States
  • NRT United States
  • Employees
  • COEP N/A
  • NRT N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • NRT Oil & Gas Production
  • Sector
  • COEP Health Care
  • NRT Energy
  • Exchange
  • COEP Nasdaq
  • NRT Nasdaq
  • Market Cap
  • COEP 32.4M
  • NRT 44.0M
  • IPO Year
  • COEP N/A
  • NRT N/A
  • Fundamental
  • Price
  • COEP $10.45
  • NRT $4.28
  • Analyst Decision
  • COEP
  • NRT
  • Analyst Count
  • COEP 0
  • NRT 0
  • Target Price
  • COEP N/A
  • NRT N/A
  • AVG Volume (30 Days)
  • COEP 60.3K
  • NRT 26.2K
  • Earning Date
  • COEP 05-09-2025
  • NRT 02-28-2025
  • Dividend Yield
  • COEP N/A
  • NRT 11.14%
  • EPS Growth
  • COEP N/A
  • NRT N/A
  • EPS
  • COEP N/A
  • NRT 0.56
  • Revenue
  • COEP N/A
  • NRT $5,942,748.00
  • Revenue This Year
  • COEP N/A
  • NRT N/A
  • Revenue Next Year
  • COEP N/A
  • NRT N/A
  • P/E Ratio
  • COEP N/A
  • NRT $7.60
  • Revenue Growth
  • COEP N/A
  • NRT N/A
  • 52 Week Low
  • COEP $2.31
  • NRT $3.88
  • 52 Week High
  • COEP $13.70
  • NRT $8.62
  • Technical
  • Relative Strength Index (RSI)
  • COEP 48.25
  • NRT 41.99
  • Support Level
  • COEP $10.00
  • NRT $4.16
  • Resistance Level
  • COEP $11.75
  • NRT $4.46
  • Average True Range (ATR)
  • COEP 1.07
  • NRT 0.20
  • MACD
  • COEP -0.12
  • NRT -0.03
  • Stochastic Oscillator
  • COEP 48.22
  • NRT 24.00

Stock Price Comparison Chart: COEP vs NRT

COEP
NRT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416182022COEP VS NRT

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About NRT North European Oil Royality Trust

North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use